Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-18

FDA Approved: ISOTRETINOIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for isotretinoin from Actavis Pharma, Inc., authorizing changes to labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)